139 related articles for article (PubMed ID: 38703321)
1. Effect of food on the pharmacokinetics and safety profiles of a new PARP inhibitor fuzuloparib capsules in healthy volunteers.
Du P; Long Y; Wang M; Huang Y; Wang Y; Chen X; Lin Y; Wu J; Shen J; Jia Y
Cancer Chemother Pharmacol; 2024 May; ():. PubMed ID: 38703321
[TBL] [Abstract][Full Text] [Related]
2. Effect of a moderate CYP3A inducer efavirenz on the pharmacokinetics of fuzuloparib: An open-label, fixed sequence study in Chinese healthy male subjects.
Hu L; Dou T; Sun Q; Tang L; Cai M; Qian W; Wang H
Invest New Drugs; 2023 Apr; 41(2):276-283. PubMed ID: 36800130
[TBL] [Abstract][Full Text] [Related]
3. A randomized, open-label, two-period crossover bridging study on fuzuloparib capsules of different specifications in healthy Chinese volunteers.
Jiang X; Tao Y; Liu Y; Shi P; Li T; Sun F; Cao Y; Wang C
Br J Clin Pharmacol; 2022 Mar; 88(3):1087-1093. PubMed ID: 34378245
[TBL] [Abstract][Full Text] [Related]
4. Unveiling the Influence of a High-Fat Meal on the Pharmacokinetics of Oral Globalagliatin, A Glucokinase Activator, in Healthy Chinese Volunteers.
Xu M; Wang Y; Wang X; Pu Z; Liu Y; Jiang C; Shen X; Sun H; Xie H
Drugs R D; 2024 Mar; 24(1):41-50. PubMed ID: 37985605
[TBL] [Abstract][Full Text] [Related]
5. Effect of fluconazole on the pharmacokinetics of fuzuloparib: an open-label, crossover study in Chinese healthy male volunteers.
Chen X; Yang F; Zhao J; Tang Q; Heng J; Deng J; Zhang J; Chen Y; Li K; Wang J
Cancer Chemother Pharmacol; 2022 Jan; 89(1):141-148. PubMed ID: 34851444
[TBL] [Abstract][Full Text] [Related]
6. The impact of rifampicin on the pharmacokinetics of fuzuloparib in healthy Chinese male volunteers.
Zhang Q; Kai J; Zhai Y; Xu N; Shentu J; Zhang Y; Liang Y; Wang Y; Wu L
Br J Clin Pharmacol; 2022 Jan; 88(1):84-90. PubMed ID: 34033139
[TBL] [Abstract][Full Text] [Related]
7. The effect of food on the pharmacokinetics of WXFL10203614, a potential selective JAK1 inhibitor, in healthy Chinese subjects.
Huang K; Shi Y; Chu N; Que L; Ding Y; Qian Z; Qin W; Gu X; Wang J; Zhang Z; Xu J; He Q
Front Pharmacol; 2022; 13():1066895. PubMed ID: 36506530
[No Abstract] [Full Text] [Related]
8. A single-dose, randomized crossover study in healthy Chinese subjects to evaluate pharmacokinetics and bioequivalence of two capsules of calcium dobesilate 0.5 g under fasting and fed conditions.
Liu Y; Cheng J; Liang L; Qian W; Ou M; Zhang M; Wang Y; Wang Y; Peng K; Jia J
PLoS One; 2023; 18(4):e0284576. PubMed ID: 37083730
[TBL] [Abstract][Full Text] [Related]
9. Food Effect on the Pharmacokinetics of VC004, a Tropomyosin Receptor Kinase Inhibitor: A Randomized Crossover Trial in Healthy Chinese Subjects.
Hu L; Sun Q; Tang L; Cai M; Qian W; Dou T; Wang H; Wu Y; Liu Y
Clin Drug Investig; 2024 Jan; 44(1):79-85. PubMed ID: 38112942
[TBL] [Abstract][Full Text] [Related]
10. Itraconazole interferes in the pharmacokinetics of fuzuloparib in healthy volunteers.
Hu C; Zhang Y; Pei T; Liu P; Zhang L
Cancer Chemother Pharmacol; 2023 Jun; 91(6):523-529. PubMed ID: 37166499
[TBL] [Abstract][Full Text] [Related]
11. Bioequivalence study of 20-mg and 100-mg temozolomide capsules (TOZ309 and Temodal
Hu C; Lin Q; Liu C; Liu J; Chen X; Li X; Zhao G; Zhang L
Cancer Chemother Pharmacol; 2020 Dec; 86(6):793-801. PubMed ID: 33089408
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics, Bioequivalence and Safety of Cloperastine in Chinese Healthy Subjects Under Fasting and Postprandial Conditions.
Luo HY; Long HZ; Zhou ZW; Xu SG; Li FJ; Cheng Y; Wen DD; Deng P; Gao LC
Drugs R D; 2022 Dec; 22(4):311-320. PubMed ID: 36369609
[TBL] [Abstract][Full Text] [Related]
13. Comparative pharmacokinetics and bioavailability of monomethyl fumarate following a single oral dose of Bafiertam® (monomethyl fumarate) versus Vumerity® (diroximel fumarate).
Rousseau FS; Wang L; Sprague TN; Lategan TW; Berkovich RR
Mult Scler Relat Disord; 2023 Feb; 70():104500. PubMed ID: 36645997
[TBL] [Abstract][Full Text] [Related]
14. Bioequivalence Study of Palbociclib Capsules in Healthy Chinese Subjects Under Fasting and Fed Conditions.
Chu NN; Zhang L; Wang J; Gu X; Ding Y; Huang K; Que LL; He Q
Clin Drug Investig; 2022 Jan; 42(1):53-63. PubMed ID: 34837169
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and bioequivalence of Ezetimibe tablet versus Ezetrol®:an open-label, randomized, two-sequence crossover study in healthy Chinese subjects.
Sun F; Liu Y; Li T; Lin P; Jiang X; Li X; Wang C; Gao X; Ma Y; Fu Y; Cao Y
BMC Pharmacol Toxicol; 2023 Feb; 24(1):7. PubMed ID: 36737825
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Ornidazole Tablets Bioequivalence in Chinese Healthy Participants Under Fasted and Fed Conditions Using Pharmacokinetic Parameters.
Wang Y; He Y; Li W; Li H; Tang L; Dai X; Pei Y; Gao L
Drugs R D; 2024 Apr; ():. PubMed ID: 38644462
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics, Bioequivalence and Safety Evaluation of Two Ticagrelor Tablets Under Fasting and Fed Conditions in Healthy Chinese Subjects.
Wang J; Zhang H; Wang R; Cai Y
Drug Des Devel Ther; 2021; 15():1181-1193. PubMed ID: 33758499
[TBL] [Abstract][Full Text] [Related]
18. Food effect on pharmacokinetics of cannabidiol oral capsules in adult patients with refractory epilepsy.
Birnbaum AK; Karanam A; Marino SE; Barkley CM; Remmel RP; Roslawski M; Gramling-Aden M; Leppik IE
Epilepsia; 2019 Aug; 60(8):1586-1592. PubMed ID: 31247132
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the Pharmacokinetics of the Phase II and Phase III Capsule Formulations of Selumetinib and the Effects of Food on Exposure: Results From Two Randomized Crossover Trials in Healthy Male Subjects.
Tomkinson H; McBride E; Martin P; Lisbon E; Dymond AW; Cantarini M; So K; Holt D
Clin Ther; 2017 Nov; 39(11):2260-2275.e1. PubMed ID: 28985960
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and Bioequivalence of Two Formulations of Valsartan 80 mg Capsules: A Randomized, Single Dose, 4-Period Crossover Study in Healthy Chinese Volunteers Under Fasting and Fed Conditions.
Wu Q; Wang X; Chen Q; Zou Y; Xu X; Li T; Yu C; Zhu F; Zhang KE; Jia J; Liu Y
Drug Des Devel Ther; 2020; 14():4221-4230. PubMed ID: 33116410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
